Clinical trials
Cancer clinical trials
Below are recruiting cancer clinical trials, each written for real people, not researchers. We’re tracking 13,110 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06528184Recruiting
Comparing HPV testing methods for cervical cancer screening
This study compares different ways of testing for HPV (the virus that causes cervical cancer) during routine screening at primary care clinics. It aims to see which testing method works best to detect the virus and prevent cancer.
Singapore, SingaporeAges 30–69 - NCT06528418Recruiting
Breath test to find lung diseases
This study uses a simple breath test to detect different lung diseases. By analyzing the chemicals in your breath, researchers hope to find a faster, non-invasive way to diagnose lung conditions. It may be an option if you have a known lung disease and have a recent CT scan.
Guangzhou, GuangdongAges 18–100 - NCT06528912Recruiting
Standard Follow-Up Program for Brain Tumor Patients
This trial tests a new follow-up program for people with brain or spinal tumors who are getting radiation therapy. The program aims to improve your care and monitor your recovery after treatment.
GroningenAges 18 years+ - NCT06528847RecruitingPhase 2
Adjuvant Benmelstobart for stage IB, grade 3 lung adenocarcinoma
This trial tests whether giving the immunotherapy drug Benmelstobart after surgery can help prevent return of a specific type of lung cancer. It is for people with stage IB, grade 3 (poorly differentiated) lung adenocarcinoma that has been completely removed.
Shanghai, Shanghai MunicipalityAges 18–74 - NCT06529081Recruiting
Radiation schedule for advanced small-cell lung cancer after chemo-immunotherapy
This study tests a specific radiation schedule (15 sessions to the chest and up to 3 sessions to other spots) for people with advanced small-cell lung cancer that responded to first-line chemo combined with immunotherapy. The goal is to see if this radiation approach can improve control of the disease.
LublinAges 18 years+ - NCT06529614Recruiting
Study of a microRNA detection test in healthy people
This trial tests a new way to detect tiny molecules called microRNAs in the body. It is looking for healthy volunteers to help see how well the detection works.
Wuhan, HubeiAges 18–75 - NCT06529809RecruitingPhase 1/Phase 2
Accelerated brachytherapy and chemo for advanced cervical cancer
This trial tests a new way of delivering radiation therapy (brachytherapy) combined with chemotherapy for advanced cervical cancer. The goal is to see if a faster, more intense radiation schedule is safe and effective.
St Louis, MissouriAges 18 years+ - NCT06531460Recruiting
Omega-3 nutrition before lung cancer surgery
This study tests whether a special nutrition drink with omega-3 (a healthy fat found in fish) can help people recover better after lung cancer surgery. You may qualify if you are about to have lung removal surgery.
Mexico CityAges 18 years+ - NCT06532422Recruiting
Recovery after kidney cancer surgery done as day surgery
This study looks at how people recover after laparoscopic (keyhole) surgery for kidney cancer when they go home the same day. It will help doctors understand if this approach is safe and improves recovery.
LyonAges 18 years+ - NCT06532539RecruitingPhase 2
Cadonilimab with radiation for recurrent endometrial cancer
This trial tests a combined treatment of the immunotherapy drug cadonilimab plus radiation and chemotherapy for endometrial cancer that has come back or spread to only a few places. The goal is to see if this combination can help control the cancer better.
Jinan, ShandongAges 18–80 - NCT06532617RecruitingPhase 2
New drug combo for advanced pancreatic cancer after first treatment
This trial tests a new drug combo (cadonilimab plus either S-1 or capecitabine) for people with advanced pancreatic cancer that has not spread to other organs and who have already tried one standard treatment. The goal is to see if this combination can help shrink or control the cancer.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06532773RecruitingDurham, North CarolinaAges 18 years+
- NCT06532877Recruiting
Telephone support for advanced GI cancer and caregivers
This study offers telephone-based support for people with advanced gastrointestinal cancer who are experiencing fatigue, and for their family caregivers. It aims to help both you and your caregiver manage the challenges of cancer care together.
Chicago, IllinoisAges 18 years+ - NCT06533384RecruitingPhase 3
PARP inhibitor or chemo plus immunotherapy after surgery for high-risk TNBC
This trial tests whether adding a PARP inhibitor or capecitabine (chemo) to a PD-1 inhibitor (immunotherapy) after surgery helps prevent triple-negative breast cancer from coming back. It's for people with high-risk disease who have completed initial treatment.
Guangzhou, GuangdongAges 18–70 - NCT06534489Recruiting
Surgery for lung cancer after chemo or targeted therapy
This trial tests whether combining chemo or targeted therapy before surgery can help people with non-small cell lung cancer that may require removing a whole lung. We want to see if this approach makes the surgery safer and more effective.
ShanghaiAges 18–75 - NCT06536504Recruiting
Music before brain surgery for stress and pain
This study looks at whether listening to live or recorded music before brain or spine surgery can help reduce stress, improve mood, and lessen pain. You may be able to join if you are scheduled for neurosurgery and can hear and speak English.
Houston, TexasAges 18 years+ - NCT06536725Recruiting
Matching chemo to prostate cancer spread to internal organs
This study is testing a new way to match chemotherapy drugs to your specific prostate cancer that has spread to internal organs. Doctors will grow a tiny 3D model of your tumor (organoid) in the lab and test which drugs work best for you.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06536868RecruitingPhase 2
Tislelizumab with chemo and radiation for extensive-stage small cell lung cancer
This trial tests a combination of an immunotherapy drug (tislelizumab) with chemotherapy and chest radiation for people with extensive-stage small cell lung cancer (SCLC) that has spread. The goal is to see if this combination helps shrink or control the cancer longer.
Jincheng, ShanxiAges 18–80 - NCT06537154RecruitingPhase 2/Phase 3
Neoadjuvant therapy for bladder cancer with active surveillance
This trial tests whether people with muscle-invasive bladder cancer can safely avoid immediate surgery or radiation after a short course of chemotherapy. Instead, they would be closely monitored and only treated if the cancer comes back.
Vancouver, British ColumbiaAges 19 years+ - NCT06538857RecruitingPhase 2
Study of CEB-01 for resectable pancreatic cancer
This trial tests an experimental drug called CEB-01 in people with pancreatic cancer that can be surgically removed. It aims to see if adding this drug to surgery improves outcomes.
Barcelona, CataloniaAges 18 years+ - NCT06539806Recruiting
Losartan for pancreatic cancer with high blood pressure
This trial tests if adding losartan (a blood pressure medicine) to standard chemotherapy helps people with advanced pancreatic cancer. It is for patients who also have high blood pressure.
TantaAges 50–85 - NCT06540872RecruitingPhase 2
Testing New PET/MRI Scan in Large DCIS
This study tests a new imaging method that combines a special PET scan (FAPI) with MRI to see if it can better find hidden invasive cancer in people with large areas of ductal carcinoma in situ (DCIS). It aims to improve surgical planning and avoid second surgeries.
Essen, North Rhine-WestphaliaAges 18 years+ - NCT06541210Recruiting
Prostate health study for Black men in Jacksonville
This study from Mayo Clinic aims to improve prostate health and reduce cancer disparities in Black men by building community partnerships in Jacksonville, Florida. It involves community leaders, health workers, and Black adults sharing their experiences and insights.
Jacksonville, FloridaAges 21–80 - NCT06540937RecruitingPhase 2
Leflunomide for MEN-1 related neuroendocrine tumors
This trial tests if leflunomide, a medication usually used for arthritis, can shrink or slow the growth of neuroendocrine tumors in people with MEN-1 gene mutations. It is for patients whose tumors have worsened after standard treatment.
BeijingAges 18–75
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cancer?
- Yes. Clin2 currently lists 13,110 recruiting cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Beyond the search
We also like to point to nonprofits doing real good in this area. We aren’t affiliated with them — we just admire the work.
- Stand Up To CancerPeople facing cancer across many types, through the research that leads to better treatments.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.